These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 30032875)

  • 1. Management of rocuronium neuromuscular block using a protocol for qualitative monitoring and reversal with neostigmine.
    Thilen SR; Ng IC; Cain KC; Treggiari MM; Bhananker SM
    Br J Anaesth; 2018 Aug; 121(2):367-377. PubMed ID: 30032875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
    Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
    Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a Protocol for the Management of Maintenance and Reversal of Rocuronium Block Using Neostigmine or Sugammadex.
    Thilen SR; Liang T; Kruse TN; Cain KC; Treggiari MM; Bhananker SM
    Anesth Analg; 2023 Jun; 136(6):1143-1153. PubMed ID: 37205804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisatracurium- and rocuronium-associated residual neuromuscular dysfunction under intraoperative neuromuscular monitoring and postoperative neostigmine reversal: a single-blind randomized trial.
    Feltracco P; Tonetti T; Barbieri S; Frigo AC; Ori C
    J Clin Anesth; 2016 Dec; 35():198-204. PubMed ID: 27871520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of reversal strategies on the incidence of postoperative residual paralysis after rocuronium relaxation without neuromuscular monitoring: A partially randomised placebo controlled trial.
    Nemes R; Fülesdi B; Pongrácz A; Asztalos L; Szabó-Maák Z; Lengyel S; Tassonyi E
    Eur J Anaesthesiol; 2017 Sep; 34(9):609-616. PubMed ID: 28030444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery of muscle function after deep neuromuscular block by means of diaphragm ultrasonography and adductor of pollicis acceleromyography with comparison of neostigmine vs. sugammadex as reversal drugs: study protocol for a randomized controlled trial.
    Cappellini I; Picciafuochi F; Ostento D; Danti G; De Gaudio AR; Adembri C
    Trials; 2018 Feb; 19(1):135. PubMed ID: 29467022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The RECITE Study: A Canadian Prospective, Multicenter Study of the Incidence and Severity of Residual Neuromuscular Blockade.
    Fortier LP; McKeen D; Turner K; de Médicis É; Warriner B; Jones PM; Chaput A; Pouliot JF; Galarneau A
    Anesth Analg; 2015 Aug; 121(2):366-72. PubMed ID: 25902322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, risk factors, and consequences of residual neuromuscular block in the United States: The prospective, observational, multicenter RECITE-US study.
    Saager L; Maiese EM; Bash LD; Meyer TA; Minkowitz H; Groudine S; Philip BK; Tanaka P; Gan TJ; Rodriguez-Blanco Y; Soto R; Heisel O
    J Clin Anesth; 2019 Aug; 55():33-41. PubMed ID: 30594097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised controlled trial of sugammadex or neostigmine for reversal of neuromuscular block on the incidence of pulmonary complications in older adults undergoing prolonged surgery.
    Togioka BM; Yanez D; Aziz MF; Higgins JR; Tekkali P; Treggiari MM
    Br J Anaesth; 2020 May; 124(5):553-561. PubMed ID: 32139135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sugammadex Versus Neostigmine for Reversal of Rocuronium Neuromuscular Block in Patients Having Catheter-Based Neurointerventional Procedures: A Randomized Trial.
    Farag E; Rivas E; Bravo M; Hussain S; Argalious M; Khanna S; Seif J; Pu X; Mao G; Bain M; Elgabaly M; Esa WAS; Sessler DI
    Anesth Analg; 2021 Jun; 132(6):1666-1676. PubMed ID: 34032663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of protocol and evaluation of postoperative residual curarization incidence in the absence of intraoperative acceleromyography - Randomized clinical trial].
    Santos FNC; Braga AFA; Ribeiro CJBL; Braga FSDS; Carvalho VH; Junqueira FEF
    Rev Bras Anestesiol; 2017; 67(6):592-599. PubMed ID: 28410818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-Dose or High-Dose Rocuronium Reversed with Neostigmine or Sugammadex for Cesarean Delivery Anesthesia: A Randomized Controlled Noninferiority Trial of Time to Tracheal Intubation and Extubation.
    Stourac P; Adamus M; Seidlova D; Pavlik T; Janku P; Krikava I; Mrozek Z; Prochazka M; Klucka J; Stoudek R; Bartikova I; Kosinova M; Harazim H; Robotkova H; Hejduk K; Hodicka Z; Kirchnerova M; Francakova J; Obare Pyszkova L; Hlozkova J; Sevcik P
    Anesth Analg; 2016 May; 122(5):1536-45. PubMed ID: 26974018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of reversal with neostigmine of low-dose rocuronium vs. reversal with sugammadex of high-dose rocuronium for a short procedure.
    Choi ES; Oh AY; Koo BW; Hwang JW; Han JW; Seo KS; Ahn SH; Jeong WJ
    Anaesthesia; 2017 Oct; 72(10):1185-1190. PubMed ID: 28493510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of cisatracurium and rocuronium block at a tactile train-of-four count of 2: should quantitative assessment of neuromuscular function be mandatory?
    Kopman AF; Zank LM; Ng J; Neuman GG
    Anesth Analg; 2004 Jan; 98(1):102-106. PubMed ID: 14693596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tactile evaluation of the response to double burst stimulation decreases, but does not eliminate, the problem of postoperative residual paralysis.
    Fruergaard K; Viby-Mogensen J; Berg H; el-Mahdy AM
    Acta Anaesthesiol Scand; 1998 Nov; 42(10):1168-74. PubMed ID: 9834799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of rocuronium induced neuromuscular block with sugammadex or neostigmine: a large observational study.
    Della Rocca G; Pompei L; Pagan DE Paganis C; Tesoro S; Mendola C; Boninsegni P; Tempia A; Manstretta S; Zamidei L; Gratarola A; Murabito P; Fuggiano L; DI Marco P
    Acta Anaesthesiol Scand; 2013 Oct; 57(9):1138-45. PubMed ID: 23849107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
    Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME
    Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of Partial Neuromuscular Block and the Ventilatory Response to Hypoxia: A Randomized Controlled Trial in Healthy Volunteers.
    Broens SJL; Boon M; Martini CH; Niesters M; van Velzen M; Aarts LPHJ; Dahan A
    Anesthesiology; 2019 Sep; 131(3):467-476. PubMed ID: 31045894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of sugammadex and neostigmine for reversal of rocuronium-induced neuromuscular blockade in children.
    Ammar AS; Mahmoud KM; Kasemy ZA
    Acta Anaesthesiol Scand; 2017 Apr; 61(4):374-380. PubMed ID: 28185260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.